Blood Supply Disruption and Conservation Strategies for Hospitals
Summary
The New York State Department of Health has issued guidance to hospitals and diagnostic and treatment centers regarding blood supply disruptions. The directive outlines strategies for conserving blood products and optimizing their use during periods of decreased availability.
What changed
The New York State Department of Health, through its Division of Hospitals and Diagnostic & Treatment Centers, has issued a directive (DAL#: 25-01) dated February 3, 2025, to healthcare providers concerning blood supply disruptions and conservation strategies. The guidance addresses a temporary decrease in blood product availability due to holidays and recent events, emphasizing the need for hospitals to adopt proactive measures to conserve existing stocks and ensure efficient utilization of critical supplies like whole blood, plasma, and red blood cells.
Healthcare providers are instructed to immediately begin inventorying, monitoring, and tracking blood product usage at system, provider, and department levels, including data on withheld products. They are also advised to optimize product usage protocols by administering minimal necessary volumes, especially in non-critical cases, to reduce waste and conserve stock. The guidance aims to help providers maintain patient care standards while managing the current strained blood supply situation.
What to do next
- Implement systems to track blood product inventory and usage at all levels.
- Collect data on cases where blood products are withheld to refine protocols.
- Optimize product usage protocols by administering minimal necessary volumes and limiting use in non-critical cases.
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.